marketcaparena
Search

    RLAY

    Relay Therapeutics, Inc.

    Company overview

    Market capitalization
    $3.88B
    Employees
    193
    Latest publication
    2026-09-29
    About Relay Therapeutics, Inc.

    Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a pan-mutant and isoform-selective phosphoinostide 3 kinase alpha, or PI3Ka, inhibitor that is in clinical development for the treatment of breast cancer, solid tumor, and vascular malformations; and aGal chaperone for Fabry diseases. It also develops RLY-8161, an oncogene driver that belongs to the RAS family of signaling proteins. In addition, the company develops lirafugratinib (RLY-4008), a receptor tyrosine kinase for the treatment of cancer. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; Elevar Therapeutics, Inc. for the development and commercialization of RLY-4008; and Pfizer Inc. for the development of RLY-2608 in combination with fulvestrant and atirmociclib. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue350,000USD3,000,000USD7,000,000USD0USD7,679,000USD0USD0USD0USD
    General And Administrative Expenses14,691,000USD———————
    Total Operating Expenses91,174,000USD81,086,000USD67,031,000USD12,502,000USD92,548,000USD20,552,000USD19,750,000USD8,765,000USD
    Operating Income-90,824,000USD-78,590,000USD-60,631,000USD-80,391,000USD-84,869,000USD-84,979,000USD-96,369,000USD-100,757,000USD
    Total Other Income Expense Net7,117,000USD5,299,000USD5,741,000USD6,242,000USD7,804,000USD8,975,000USD8,264,000USD8,545,000USD
    Net Income-83,707,000USD-73,291,000USD-54,890,000USD-74,149,000USD-77,065,000USD-76,004,000USD-88,105,000USD-92,212,000USD
    Cost Of Revenue—504,000USD599,000USD67,889,000USD—64,427,000USD76,619,000USD91,992,000USD
    Gross Profit—2,496,000USD6,401,000USD-67,889,000USD7,679,000USD-64,427,000USD-76,619,000USD-91,992,000USD
    Research Development—70,563,000USD55,415,000USD68,262,000USD73,809,000USD68,075,000USD76,619,000USD91,992,000USD
    Selling General Administrative—11,027,000USD12,963,000USD12,075,000USD18,739,000USD16,309,000USD19,750,000USD20,139,000USD
    Interest Income—5,352,000USD5,710,000USD6,407,000USD7,813,000USD8,974,000USD8,274,000USD8,547,000USD
    Net Interest Income—5,352,000USD5,710,000USD6,407,000USD7,813,000USD8,974,000USD8,274,000USD8,547,000USD
    Income Before Tax—-73,291,000USD-54,890,000USD-74,149,000USD-77,065,000USD-76,004,000USD-88,105,000USD-92,212,000USD
    Net Income From Continuing Ops—-73,291,000USD-54,890,000USD-74,149,000USD-77,065,000USD-76,004,000USD-88,105,000USD-92,212,000USD
    Ebit—-73,291,000USD-54,890,000USD-74,149,000USD-77,065,000USD-76,004,000USD-88,105,000USD-112,131,000USD
    Ebitda—-72,787,000USD-57,848,000USD-73,401,000USD-75,857,000USD-74,670,000USD-86,738,000USD-110,763,000USD
    Depreciation And Amortization—504,000USD-2,958,000USD748,000USD1,208,000USD1,334,000USD1,367,000USD1,368,000USD
    Reconciled Depreciation—504,000USD599,000USD748,000USD1,208,000USD1,334,000USD1,367,000USD1,368,000USD
    Unclassified Operating Expenses——-1,347,000USD-67,835,000USD—-63,832,000USD-76,619,000USD-103,366,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USD
    Total Revenue0USD
    Cost Of Revenue2,845,000USD
    Gross Profit-2,845,000USD
    Research Development70,306,000USD
    Selling General Administrative13,742,000USD
    Total Operating Expenses84,048,000USD
    Operating Income-84,048,000USD
    Interest Income8,801,000USD
    Interest Expense0USD
    Net Interest Income8,801,000USD
    Income Before Tax-75,305,000USD
    Income Tax Expense-8,801,000USD
    Net Income-66,504,000USD
    Net Income From Continuing Ops-75,305,000USD
    Ebit-84,048,000USD
    Ebitda-81,203,000USD
    Depreciation And Amortization2,845,000USD
    Reconciled Depreciation2,845,000USD
    Total Other Income Expense Net8,743,000USD
    Net Income Applicable To Common Shares-75,305,000USD
    SourceLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets967,457,000USD699,613,000USD621,331,000USD670,000,000USD728,841,000USD799,362,000USD871,296,000USD930,115,000USD
    Cash And Equivalents121,189,000USD———————
    Total Current Assets928,082,000USD658,462,000USD578,279,000USD624,014,000USD680,392,000USD739,659,000USD809,204,000USD865,129,000USD
    Other Current Assets8,413,000USD16,397,000USD23,761,000USD27,583,000USD23,617,000USD29,304,000USD27,881,000USD25,520,000USD
    Total Liabilities77,448,000USD———————
    Total Current Liabilities50,804,000USD29,751,000USD25,578,000USD32,604,999USD32,525,000USD37,052,000USD50,729,000USD46,968,000USD
    Other Current Liabilities1,252,000USD———————
    Total Stockholder Equity890,009,000USD642,183,000USD567,060,000USD607,709,000USD665,658,000USD721,081,000USD777,792,000USD838,861,000USD
    Total Equity Including Noncontrolling Interest890,009,000USD———————
    Property Plant Equipment Net38,039,000USD39,815,000USD41,716,000USD43,728,000USD46,191,000USD55,284,000USD57,673,000USD60,567,000USD
    Accounts Payable11,459,000USD4,104,000USD7,705,000USD2,752,000USD5,176,000USD8,450,000USD14,097,000USD6,867,000USD
    Short Term Debt4,014,000USD3,888,000USD3,765,000USD3,643,000USD3,525,000USD5,930,000USD5,727,000USD5,529,000USD
    Common Stock211,000USD182,000USD168,000USD168,000USD168,000USD168,000USD168,000USD167,000USD
    Retained Earnings-2,171,767,000USD-2,088,060,000USD-2,014,769,000USD-1,959,879,000USD-1,885,730,000USD-1,815,355,000USD-1,738,290,000USD-1,662,286,000USD
    Accumulated Other Comprehensive Income-1,553,000USD-172,000USD733,000USD492,999USD-163,000USD38,000USD-991,000USD2,509,000USD
    Total Liab—57,430,000USD54,271,000USD62,291,000USD63,183,000USD78,281,000USD93,504,000USD91,254,000USD
    Other Current Liab—21,759,000USD14,108,000USD26,209,999USD23,824,000USD22,672,000USD23,226,000USD34,572,000USD
    Capital Stock—182,000USD168,000USD168,000USD168,000USD168,000USD168,000USD167,000USD
    Cash—204,589,000USD84,018,000USD91,564,000USD113,941,000USD93,542,000USD124,287,000USD152,357,000USD
    Cash And Short Term Investments—642,065,000USD554,518,000USD596,431,000USD656,775,000USD710,355,000USD781,323,000USD839,609,000USD
    Net Debt—-173,022,000USD-51,560,000USD-58,235,000USD-79,758,000USD-46,383,000USD-75,785,000USD-102,542,000USD
    Short Long Term Debt Total—31,567,000USD32,458,000USD33,329,000USD34,183,000USD47,159,000USD48,502,000USD49,815,000USD
    Short Term Investments—437,476,000USD470,500,000USD504,867,000USD542,834,000USD616,813,000USD657,036,000USD687,252,000USD
    Property Plant Equipment Gross—39,815,000USD63,263,000USD43,728,000USD46,191,000USD55,284,000USD86,585,000USD60,567,000USD
    Common Stock Shares Outstanding—179,849,137shares171,586,558shares172,389,209shares171,264,622shares169,233,155shares167,337,579shares140,229,056shares
    Non Current Assets Total—41,151,000USD43,052,000USD45,986,000USD48,449,000USD59,703,000USD62,092,000USD64,986,000USD
    Non Current Liabilities Total—27,679,000USD28,693,000USD29,686,000USD30,658,000USD41,229,000USD42,775,000USD44,286,000USD
    Non Currrent Assets Other—1,336,000USD1,336,000USD2,258,000USD2,258,000USD2,119,000USD2,119,000USD2,119,000USD
    Net Working Capital—628,711,000USD552,701,000USD591,409,000USD647,867,000USD702,607,000USD758,475,000USD818,161,000USD
    Unclassified Non Current Liabilities—27,679,000USD28,693,000USD29,686,000USD30,658,000USD41,229,000USD42,775,000USD44,286,000USD
    Unclassified Equity—2,730,051,000USD2,580,760,000USD2,566,759,001USD2,551,215,000USD2,536,062,000USD2,516,737,000USD2,498,304,000USD
    Intangible Assets—————2,300,000USD2,300,000USD2,300,000USD
    Current Deferred Revenue——————7,679,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets621,331,000USD871,296,000USD843,980,000USD1,099,771,000USD1,008,443,000USD799,829,000USD393,068,000USD428,611,000USD
    Other Current Assets23,761,000USD27,881,000USD3,315,000USD3,259,000USD13,229,000USD9,385,000USD4,720,000USD2,597,000USD
    Total Liab54,271,000USD93,504,000USD91,977,000USD149,553,000USD110,635,000USD36,536,000USD573,506,000USD539,538,000USD
    Total Stockholder Equity567,060,000USD777,792,000USD752,003,000USD950,218,000USD897,808,000USD763,293,000USD-180,438,000USD-110,927,000USD
    Other Current Liab14,108,000USD23,226,000USD1,204,000USD48,855,000USD13,953,000USD5,760,000USD3,746,000USD1,982,000USD
    Common Stock168,000USD168,000USD127,000USD121,000USD109,000USD90,000USD4,000USD3,000USD
    Capital Stock168,000USD168,000USD127,000USD121,000USD109,000USD90,000USD4,000USD3,000USD
    Retained Earnings-2,014,769,000USD-1,738,290,000USD-1,400,582,000USD-1,058,609,000USD-768,100,000USD-404,228,000USD-189,482,000USD-114,177,000USD
    Cash84,018,000USD124,287,000USD143,736,000USD151,794,000USD280,119,000USD447,646,000USD41,954,000USD421,505,000USD
    Cash And Short Term Investments554,518,000USD781,323,000USD750,086,000USD998,917,000USD958,073,000USD678,061,000USD355,816,000USD421,505,000USD
    Total Current Assets578,279,000USD809,204,000USD770,103,000USD1,019,505,000USD976,242,000USD770,100,000USD360,536,000USD424,102,000USD
    Total Current Liabilities25,578,000USD50,729,000USD30,269,000USD63,709,000USD24,321,000USD13,632,000USD11,986,000USD6,865,000USD
    Net Debt-51,560,000USD-75,785,000USD-90,270,000USD-94,052,000USD-257,219,000USD-423,224,000USD-17,122,000USD-421,327,000USD
    Short Term Debt3,765,000USD5,727,000USD4,964,000USD4,276,000USD1,844,000USD1,521,000USD1,249,000USD178,000USD
    Short Long Term Debt Total32,458,000USD48,502,000USD53,466,000USD57,742,000USD22,900,000USD24,422,000USD24,832,000USD178,000USD
    Short Term Investments470,500,000USD657,036,000USD606,350,000USD847,123,000USD677,954,000USD230,415,000USD313,862,000USD0USD
    Accounts Payable7,705,000USD14,097,000USD9,211,000USD10,578,000USD8,276,000USD6,351,000USD6,991,000USD4,705,000USD
    Property Plant Equipment Net41,716,000USD57,673,000USD68,870,000USD75,388,000USD27,323,000USD28,829,000USD31,654,000USD3,631,000USD
    Property Plant Equipment Gross63,263,000USD86,585,000USD92,452,000USD93,777,000USD41,690,000USD28,829,000USD31,654,000USD3,631,000USD
    Accumulated Other Comprehensive Income733,000USD-991,000USD-196,000USD-10,420,000USD-1,088,000USD64,000USD325,000USD-4,649,000USD
    Common Stock Shares Outstanding171,586,558shares142,867,844shares122,576,527shares112,233,670shares95,136,719shares90,188,044shares4,281,169shares2,485,163shares
    Non Current Assets Total43,052,000USD62,092,000USD73,877,000USD80,266,000USD32,201,000USD29,729,000USD32,532,000USD4,509,000USD
    Non Current Liabilities Total28,693,000USD42,775,000USD61,708,000USD85,844,000USD86,314,000USD22,904,000USD561,520,000USD532,673,000USD
    Non Currrent Assets Other1,336,000USD2,119,000USD2,707,000USD2,578,000USD2,578,000USD900,000USD878,000USD878,000USD
    Net Working Capital552,701,000USD758,475,000USD739,834,000USD955,796,000USD951,921,000USD756,468,000USD348,550,000USD417,237,000USD
    Unclassified Non Current Liabilities28,693,000USD42,775,000USD48,502,000USD21,088,000USD-65,258,000USD—561,208,000USD531,567,000USD
    Unclassified Equity2,580,760,000USD2,516,737,000USD2,152,527,000USD2,019,005,000USD1,666,778,000USD1,167,277,000USD8,711,000USD7,893,000USD
    Intangible Assets—2,300,000USD2,300,000USD2,300,000USD2,300,000USD———
    Current Deferred Revenue—7,679,000USD14,890,000USD—248,000USD5,563,000USD3,413,000USD1,864,000USD
    Net Receivables——0USD5,219,000USD4,940,000USD82,654,000USD——
    Non Current Liabilities Other——13,206,000USD32,378,000USD86,314,000USD22,904,000USD156,000USD553,000USD
    Unclassified Current Assets——16,702,000USD—————
    Other Liab———32,378,000USD65,258,000USD3,000USD156,000USD553,000USD
    Other Assets———2,578,000USD2,578,000USD23,479USD878,000USD878,000USD
    Inventory———12,110,000USD-682,491,000USD-238,069,000USD——
    Net Tangible Assets———947,918,000USD895,508,000USD763,293,000USD-180,438,000USD-110,927,000USD
    Unclassified Non Current Assets———-2,578,000USD-2,578,000USD———
    Unclassified Current Liabilities—————-5,563,000USD-3,413,000USD-1,864,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-73,291,000USD-54,890,000USD-74,149,000USD-70,375,000USD-77,065,000USD-76,004,000USD-88,105,000USD-92,212,000USD
    Depreciation504,000USD-258,000USD748,000USD-392,000USD1,208,000USD1,334,000USD-8,767,000USD1,368,000USD
    Stock Based Compensation10,537,000USD13,067,000USD15,527,000USD14,500,000USD19,325,000USD17,635,000USD22,484,000USD26,832,000USD
    Other Non Cash Items-782,000USD35,000USD-748,000USD2,915,000USD-1,597,000USD-2,282,000USD20,127,000USD-14,665,000USD
    Change In Working Capital11,920,000USD-2,819,000USD-3,497,000USD-1,909,000USD-15,081,000USD1,449,000USD-20,822,000USD12,844,000USD
    Total Cash From Operating Activities-51,112,000USD-44,865,000USD-62,119,000USD-55,261,000USD-73,210,000USD-57,868,000USD-75,083,000USD-65,833,000USD
    Capital Expenditures0USD-1,000USD-1,000USD-26,000USD-384,000USD0USD-227,000USD-11,000USD
    Free Cash Flow-51,112,000USD-44,866,000USD-62,118,000USD-55,287,000USD-73,594,000USD-57,868,000USD-75,310,000USD-65,844,000USD
    Investments32,901,000USD35,464,000USD39,725,000USD75,146,000USD42,465,000USD28,998,000USD-126,162,000USD45,550,000USD
    Total Cashflows From Investing Activities32,901,000USD35,463,000USD39,725,000USD75,146,000USD42,465,000USD28,998,000USD-126,162,000USD45,550,000USD
    Total Cash From Financing Activities138,782,000USD934,000USD17,000USD653,000USD0USD800,000USD218,889,000USD1,542,000USD
    Issuance Of Capital Stock137,090,000USD0USD0USD0USD0USD0USD218,157,000USD0USD
    Change In Cash120,571,000USD-8,468,000USD-22,377,000USD20,538,000USD-30,745,000USD-28,070,000USD17,644,000USD-18,741,000USD
    Begin Period Cash Flow85,354,000USD93,822,000USD113,941,000USD95,661,000USD126,406,000USD152,357,000USD136,832,000USD152,866,000USD
    End Period Cash Flow205,925,000USD85,354,000USD91,564,000USD116,199,000USD95,661,000USD124,287,000USD154,476,000USD134,125,000USD
    Other Cashflows From Financing Activities138,782,000USD934,000USD17,000USD——266,692,000USD732,000USD1,542,000USD
    Unclassified Financing Cash Flow-137,090,000USD————-265,892,000USD217,028,000USD—
    Sale Purchase Of Stock—427,000USD—653,000USD——1,129,000USD—
    Change To Account Receivables—————0USD0USD0USD
    Other Cashflows From Investing Activities———————45,561,000USD
    Unclassified Investing Cash Flow———————-45,550,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USD
    Net Income-276,479,000USD-337,708,000USD-341,973,000USD-290,509,000USD-363,872,000USD-52,412,000USD-48,785,000USD
    Depreciation-1,392,000USD5,464,000USD5,269,000USD4,130,000USD3,925,000USD3,549,000USD2,154,000USD
    Stock Based Compensation62,419,000USD94,139,000USD86,031,000USD56,138,000USD48,454,000USD31,960,000USD2,887,000USD
    Other Non Cash Items3,303,000USD-25,622,000USD-17,185,000USD-10,495,000USD139,743,000USD-416,000USD9,000USD
    Change To Account Receivables0USD0USD5,219,000USD97,000USD77,794,000USD-75,000,000USD-82,654,000USD
    Change In Working Capital-23,306,000USD14,620,000USD-32,458,000USD11,246,000USD97,344,000USD-85,170,000USD-400,000USD
    Total Cash From Operating Activities-235,455,000USD-249,107,000USD-300,316,000USD-229,490,000USD-74,406,000USD-102,489,000USD-44,135,000USD
    Capital Expenditures-410,000USD-2,018,000USD-4,126,000USD-9,062,000USD-3,471,000USD-1,931,000USD-1,687,000USD
    Free Cash Flow-235,865,000USD-251,125,000USD-304,442,000USD-238,552,000USD-77,877,000USD-104,420,000USD-45,822,000USD
    Investments193,209,000USD-41,083,000USD51,020,000USD-188,745,000USD-450,742,000USD81,672,000USD-1,680,000USD
    Total Cashflows From Investing Activities192,799,000USD-41,083,000USD257,634,000USD-188,745,000USD-479,511,000USD81,672,000USD-1,680,000USD
    Total Cash From Financing Activities1,604,000USD270,153,000USD34,753,000USD289,910,000USD388,090,000USD426,509,000USD394,972,000USD
    Sale Purchase Of Stock1,080,000USD1,479,000USD—1,686,000USD5,880,000USD429,016,000USD-82,000USD
    Issuance Of Capital Stock0USD265,892,000USD9,363,000USD284,744,000USD382,210,000USD427,800,000USD394,255,000USD
    Change In Cash-41,052,000USD-20,037,000USD-7,929,000USD-128,325,000USD-165,827,000USD405,692,000USD349,157,000USD
    Begin Period Cash Flow126,406,000USD146,443,000USD154,372,000USD282,697,000USD448,524,000USD42,832,000USD73,226,000USD
    End Period Cash Flow85,354,000USD126,406,000USD146,443,000USD154,372,000USD282,697,000USD448,524,000USD422,383,000USD
    Other Cashflows From Financing Activities1,604,000USD4,261,000USD4,472,000USD5,166,000USD5,880,000USD1,216,000USD394,972,000USD
    Unclassified Financing Cash Flow-1,080,000USD264,413,000USD20,918,000USD283,058,000USD376,330,000USD——
    Other Cashflows From Investing Activities—101,000USD—-179,683,000USD-450,742,000USD83,603,000USD7,000USD
    Unclassified Investing Cash Flow—1,917,000USD210,740,000USD188,745,000USD425,444,000USD-81,672,000USD1,680,000USD
    Change To Inventory——-31,879,000USD—21,460,000USD-10,331,000USD—
    Change To Liabilities———21,797,000USD21,932,000USD-410,000USD1,232,000USD
    Cash And Cash Equivalents Changes———-128,325,000USD-165,827,000USD405,692,000USD—
    Net Borrowings—————-2,507,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2024Yearly · 2024-12-31ProductResearch And Development Services300,000USD0000950170-25-027756
    FY 2024Yearly · 2024-12-31ProductTransfer Of Active Pharmaceutical Ingredient100,000USD0000950170-25-027756
    FY 2024Yearly · 2024-12-31ProductTransfer Of License And Related Know How9,600,000USD0000950170-25-027756
    FY 2023Yearly · 2023-12-31ProductOther46,000USD0000950170-25-027756
    FY 2023Yearly · 2023-12-31ProductResearch And Development Services1,400,000USD0000950170-25-027756
    FY 2023Yearly · 2023-12-31ProductTransfer Of Active Pharmaceutical Ingredient100,000USD0000950170-25-027756
    FY 2023Yearly · 2023-12-31ProductTransfer Of License And Related Know How24,000,000USD0000950170-25-027756
    FY 2022Yearly · 2022-12-31ProductOther281,000USD0000950170-25-027756
    FY 2022Yearly · 2022-12-31ProductResearch And Development Services700,000USD0000950170-25-027756
    FY 2022Yearly · 2022-12-31ProductTransfer Of Active Pharmaceutical Ingredient100,000USD0000950170-25-027756
    FY 2022Yearly · 2022-12-31ProductTransfer Of License And Related Know How300,000USD0000950170-25-027756
    FY 2021Yearly · 2021-12-31ProductResearch And Development Services1,700,000USD0000950170-24-018797
    FY 2021Yearly · 2021-12-31ProductTransfer Of Active Pharmaceutical Ingredient300,000USD0000950170-24-018797
    FY 2021Yearly · 2021-12-31ProductTransfer Of License And Related Know How600,000USD0000950170-24-018797
    FY 2020Yearly · 2020-12-31ProductLicense And Transfer Agreement82,654,000USD0001564590-21-015518
    FY 2020Yearly · 2020-12-31ProductResearch And Development Services0USD0001564590-21-015518
    FY 2020Yearly · 2020-12-31ProductTransfer Of Active Pharmaceutical Ingredients0USD0001564590-21-015518

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.